Kodak share soars post active drug ingredient development deal

Author : Saipriya Iyer | Published Date : 2020-07-30 

Shares of Eastman Kodak, an American technology company, have recently increased, following the announcement of a deal by the U.S. President Donald Trump. The agreement is regarding the President’s collaboration with the company to produce active ingredients for generic medicines to fight against the deadly COVID-19 disease.

In the extended trading, the shares of Kodak have soared by more than 318%, to nearly $25.26 per share. The U.S. government has offered a $765 million loan to the company to commence the production of ingredients for the generic drugs, under the Defense Production Act.

The U.S. president has reportedly stated that the country’s 33rd adoption of the Defense Production Act will mobilize Kodak in manufacturing active pharmaceutical ingredients. This will also aid America in becoming the premier medical supplier and manufacturer.

The photography company has cited that it will provide essential pharmaceutical components to meet the chronic shortages in the nation, as defined by the U.S. FDA. The recent 1,300% increase in the stock price has recently enabled it to record a market capitalization of over $1.5 billion. Prior to this, the company registered a value of nearly $115 million.

To ensure rapid production, Kodak will expand its existing facilities in St. Paul, Minnesota, New York, and Rochester, under a new arm of Kodak Pharmaceuticals.

As per the statement made by Jim Continenza, Executive Chairman of Kodak, the company is excited to play a key role in strengthening the country’s self-sufficiency by offering major ingredients in the U.S. It will leverage its heritage in quality and innovation, deep expertise in chemicals production, and vast infrastructure to advance America as a reliable pharmaceutical supply chain.

In 2012, the company had filed for bankruptcy due to the shifting consumer preferences to digital cameras. The recent deal to enter the drug production business will present a significant growth opportunity for the company.

Source credit:

About Author

Saipriya Iyer

Saipriya Iyer

Saipriya Iyer presently works as a content developer for fractovia.org. Having dabbled with the domain of content creation for nearly half a decade, she now boasts of an enviable portfolio, holding substantial experience in penning down pieces related to technology, finance, and a wide spectrum of other industry verticals. A qualified computer engineering graduate from the University of Pune, Saipriya can often be found leveraging her knowledge of software technology and electronics in her write-ups. She can be contacted at- [email protected] | https://twitter.com/saipriya_i

Related News

Ramping production of lithium-ion batteries to accelerate tert-amylbenzene demand in Asia Pacific

Published Date: 2021-01-05         Author: Saipriya Iyer

As an active pharmaceutical ingredient (API) used in various clinical products to being used as an electronic additive in the making of lithium-ion batteries, tert amylbenzene (TAB) has gained wide-spread recognition across diverse industries. The chemical substance acts as a crucial intermediate in... Read More

FMCG firms to explore oral care market amidst rising hygiene concerns

Published Date: 2021-01-04         Author: Saipriya Iyer

Fast-moving consumer goods businesses in India are reportedly expanding their range of oral care, joining new and niche categories including mouthwashes, ayurvedic mouth cleansers, and mouth sprays as customer issues around general hygiene persists. For the record, Dabur India and Colgate Palmoli... Read More

Microsoft to introduce ‘Google assistant’ alternative for Windows

Published Date: 2020-12-28         Author: Saipriya Iyer

Microsoft Corporation, an American multinational technology giant, is reportedly testing a new voice launcher feature which will enable users to interact with files and applications using voice commands. According to trusted sources, the feature is currently available to select group of users who... Read More

© 2021 Fractovia. All Rights Reserved